Interestingly, the hypermethylated RAS association (RalGDS/AF-6) domain family member 1A gene (RASSF1A) has been reported to have clinical sensitivity of 67%–75% for stage IV breast cancer [9]. Here, RASSF1 is linked to breast carcinoma.